It was five years ago today that then-Gov. Charlie Baker declared a State of Emergency in Massachusetts due to the rapidly ...
2d
MedPage Today on MSNHigh-Dose Vitamin D Reduces Disease Activity in Early Multiple Sclerosis"It was important to conduct a large randomized controlled trial to evaluate the efficacy of high-dose cholecalciferol as ...
In Part A of the trial, subjects will be given nine intravenous infusions of either the drug or placebo over a six-month period.
X-ELIO, a global leader in the renewable energy sector, and the Net Zero Consortium for Buyers (NZCB) have announced the ...
6dOpinion
MedPage Today on MSNHow a Book Is Undermining Progress Against Alzheimer'sSystematic fraud -- led by a "cabal of self-interested researchers, government accomplices, and corporate greed" in the words ...
Sage Therapeutics (NASDAQ:SAGE) stock drops as Bank of America issues an Underperform rating citing an end to Biogen's (BIIB) ...
A new analysis provides substantial evidence that paramagnetic rim lesions drive disability in MS and are targetable with a ...
A detailed review of a 6-month clinical trial further reinforces strong experimental evidence that a ketogenic diet may offer ...
Technology company Cisco is among the groups involved in six virtual power purchase agreements (VPPAs) to secure energy from ...
The stock's fall snapped a seven-day winning streak.
Biogen, Cisco, IDEXX Laboratories and Waters Corporation entered into a new aggregated procurement under the Net Zero ...
Biogen (BIIB) announced the initiation of dosing in the global clinical study, TRANSCEND. The Phase 3 study will evaluate the efficacy and ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results